Given that the hallmark of vascular NF-κB activation involves IL-6 production, and it has been demonstrated that the promoter region of the IL-6 gene contains a putative NF-κ B-binding site [55], we investigated IL-6 production in CAF Exo-treated CRC cells. The gene discussed is IL6; the disease is colorectal carcinoma.